• OPEN AN ACCOUNT
Indian Indices
Nifty
25,330.25 91.15
(0.36%)
Sensex
82,693.71 313.02
( 0.38%)
Bank Nifty
55,493.30 345.70
( 0.63%)
Nifty IT
36,447.15 235.00
( 0.65%)
Global Indices
Nasdaq
45,773.62 130.84
(-0.29%)
Dow Jones
6,626.82 -9.46
(-0.14%)
Hang Seng
44,831.00 -71.27
(-0.16%)
Nikkei 225
9,208.37 12.71
(0.14%)
Forex
USD-INR
88.02 -0.26
(-0.29%)
EUR-INR
104.02 0.45
(0.44%)
GBP-INR
120.02 0.37
(0.31%)
JPY-INR
0.60 0.00
(0.30%)

EQUITY - MARKET SCREENER

ABS Marine Services Ltd
Industry :  Shipping
BSE Code
ISIN Demat
Book Value()
33676
INE0QRV01016
96.4463544
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ABSMARINE
17.11
455.77
EPS(TTM)
Face Value()
Div & Yield %
10.85
10
0
 

spencer`s retail ltd
Lupin slides after receiving six observations from USFDA for Nagpur facility
Sep 17,2025
According to a regulatory filing, the inspection was carried out from 8 September to 16 September 2025.

The company stated that it will address the observations and respond to the U.S. FDA within the stipulated timeframe. It is committed to complying with CGMP quality standards across all its facilities.

Lupin is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. It specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients.

The company's consolidated net profit jumped 52.13% to Rs 1,219.03 crore on 11.78% increase in income from operations to Rs 6,163.75 crore in Q1 FY26 over Q1 FY25.